Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$65M+ cash and all this? Just waiting to erupt.
PUR1800 Data (which will validate iSPERSE) + 2.4Billion U.S. market for AECOPD
PUR3100 P1/P2 Trial Start - which will validate iSPERSE in taking a previously $800M acquired failed P3 (b/c of safety) formulation to market.
FEND - Beginning of marketing campaign & wildcards with WHO, CDC, Next Breath, and beyond - coming out party coming soon.
PUR1900 (Pulmazole) - FDA Fast Trac, QIDP Status, and partnered with India's largest inahlation company -- looking for other news ahead of 2023 here (LPAD?)
Nocion Partnership - At some point they will look to bring in iSPERSE into their formulations - which are in P2 moving to P3.
JnJ Partnership - At some point, won't be surprised to see JnJ re-enter on PUR1800 for long-term dosage of Lung Cancer.
Oxeia Partnership - Given Ted Raad just joined their BoD, and they have iSPERSE mentioned in a patent - wouldn't be surprised to see something.
iSPERSE as a Platform = $$$
$PULM
yep~!
lost good $$$ on PULM turd
2 offerings back to back then an R/S
no wonder im ready to retire
Last evening PULM bounced up to $0.45! I'm wondering if it will test the most recent high $0.469 as soon as today? $0.78 will be hit again in the coming days/weeks anyway...
PULM turned out to be a POS...
$PULM This is going to rip so hard...
Yes management likely to issue a bit more additional stock options/etc. -- yet on a weighted average basis of available employee compensation, the vast majority of shares have already been issued & vested at much higher levels ($1.25-$1.35 level).
And don't discount Ted's 1.2million option position at a strike price of $1.35. $100 stock price implying a 10billion valuation = $100M payday for Ted Raad. I can all but guarantee you he is not interested in just being in the money at ~$3-$5, he's looking for a big big payout too for his effort.
Why am I throwing around $100 stock price with ease? Well remember - PUR1800 AECOPD US market alone is $2.4B Revenue in peak year (5-7 years out?). Implying a $5B market capitalization with 15% EBITDA and 15x Multiple on such. And this is just one indication, in one market...
Fun and games nearing an end - big revaluation higher coming in Q1 2022.
$0.4 will be broken down very soon! Which means we won't see any price higher than $0.8 in the future!
I know. But on-going Super Heavy Diluting crashed this Huge Diluting Pos Scam to $0.4 from this-month-high $0.7799!
So we should see at least a couple of more New lows until it hits $0.38...
I'm glad to have sold all my shares at $0.45 ~ $0.44 this early morning! I'll buy them back at $0.38 ~ $0.42. Currently I just bought some shares at $0.42 and ready to sell them at $0.45 or higher price levels.
hmmmmmm...interesting! Cash @$1.11 per share vs. $0.40 pps.
Source: Page F-3, December 31, 2020 PULM 10-k.
As I predicted exactly PULM finally crashed to $0.4 today from its most recent high $1.05 (which was created in the after-hour session)!
So this hidden gem is currently at Hyper Oversold status --- from $1.05 to $0.4!
The diamond-in-rough is also Super Undervalued now!
I'm taking my first position $0.40xx today because I believe the Real Bottom is very closing by $0.4. Let's see if any Good News will push it back to $0.86 ~ $1.04 again since the analyst's target is $1.5!
Wall Street is positive on Pulmatrix Inc (PULM). On average, analysts give Pulmatrix Inc a Strong Buy rating. The average price target is $5, which means analysts expect the stock to gain by 941.67%
https://www.investorsobserver.com/news/stock-update/what-is-wall-streets-target-price-for-pulmatrix-inc-pulm-stock-thursday
PULM .43 will have its day just like sopa grtx and so many others that got beat up and looked like absolute chit
they almost always go at some point
its cyclical
Wow, a Blood-Wash day for all the PULM shareholders! Do you know what is the public offering price? We should see $0.4 as soon as tomorrow though this Huge Diluting Pos Scam just crashed to $0.4733 so far!
Very true for your statement in USA! The US government always works for the rich people while they do not care the middle class at all!
Very suspicious is FEND still giving us royalties?
https://www.hellofend.com/
Raise more money to buy back stock and still vote on a reverse split. Certainly, an interesting approach when you already have $50+M cash on hand. The only signal that sends is a big FU to investors.
The stock market is rigged for the rich...
period.
At these prices and with $54M cash on hand PULM should buy back half the float.
The Huge Diluting Pos Scam crashed to $0.6 today! Sell ASAP before it is too late...
Why PULM crashed from the most recent high $1.05 to such low price levels without any bad news? Did I miss any negative bad news?
How could my buying order at $0.6201 was not filled any yesterday but the price dropped to much below it?
I had buying orders at 0.6201 all the way till 0.5 yesterday! Why no any fill at all?
Anyway the Real Bottom is $0.6201 as I can tell!
Thanks for sharing your opinion. I humbly disagree.
$PULM
LOL, the Huge Diluting Pos Scam (PULM) crashed to $0.7667 again in the after-hour session of last Friday! So the New low $0.67 will be tested again in the coming days...
I bet $0.5xxx will be the New Bottom before any decent bounce!
Why? I dont see a catalist for this..,
I like the way you think.
lol barking up the wrong tree here .
$PULM Hard to believe that the future is not bright here.
This company has a $43M market cap (risk has been taken out), $40M
+ cash on hand with multi-year runway, no debt, granted IP approvals, FDA & MHRA approvals, distinguished scientific advisors, distinguished founders, great royalty deal on a coming new form of airway hygiene, a pipeline which assuming can be commercialized is worth billions, in-roads with some of the largest pharma companies in the world -- and a repeatable delivery platform which just needs that one breakthrough example to prove to the market.
Advice is being given to management by people who have been in this industry for a long time. Ted is not a science guy he is a business guy. Management and employee compensation package are tied to prices $1.30++. Warrant holders are tied to $2.00+ prices.
$2.00 is only a $100M market cap (lol!). The risk/reward ratio here is extremely favorable at this point in time.
In my opinion, obviously.
I like our odds. Breakthrough news coming... (?)
CIPLA? Hello, anyone home? PUR1900 LPAD?
FEND? Hello, new product launch?
J&J? Hello, are you interested in PUR1800 for Lung Cancer with chronic dosing showing improved safety profile?
Nocion? Hello, iSPERSE is there once your API clears
$PULM
Oh, you're fun.
Or maybe a bounce from here.
One could hope anyway.
$PULM
Why iSPERSE; 2012 Article; Still True Today
Will we see iSPERSE be live up to it's long-promised benefits?
https://drug-dev.com/a-next-generation-inhaled-dry-powder-delivery-platform/
PUR1900 Study Status Update as of 8/25/21 as well? Coinciding?
https://clinicaltrials.gov/ct2/history/NCT03960606?V_8=View#ROutcomeMeasures
$PULM
Cipla Positive PUR1900 Comment in Annual Report (8/25/21)
The six months animal toxicitystudy for Pulmazole concluded successfully. We are now moving to a global Phase 2b study and a possible India Phase 2b/3 study for antifungal inhaled Itraconazole
$PULM
Page 44
https://www.cipla.com/sites/default/files/CIPLA-AR-2020-21-Single-Page.pdf
$PULM $0.82 -- let it rip. Global Ubiquity coming for FEND & iSPERSE.
....! Let's see the push now.
$PULM
$PULM , just added some more...
Followers
|
72
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3545
|
Created
|
10/21/15
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |